Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-027279
Filing Date
2019-11-14
Accepted
2019-11-14 16:23:25
Documents
1
Period of Report
2019-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3094
  Complete submission text file 0000899243-19-027279.txt   4431
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Bailey Jeffrey Allen (Reporting) CIK: 0001500210 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 191220708